Efficacy of usage of pneumococcal 7-valent vaccine in prophylaxis of pneumococcal infection in Novosibirsk children from risk groups
In order to prevent children morbidity and mortality 116 children aged from 6 months to 5 years from 2 risk groups (1 — with bronchial-pulmonary dysplasia and 2 — with congenital heart defects) were vaccinated with pneumococcal 7-valent conjugated vaccine in 2011 at the expense of municipal budget....
Main Authors: | O. A. Beletskaya, Yu.N. Gorbatykh, A. N. Shmakov, N. Yu. Ishalina, T. Yu. Ivleva, N. V. Kukhtinova |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2013-03-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/356 |
Similar Items
-
Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01) -
THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01) -
The effectiveness of pneumococcal vaccination and dynamics of acute otitis media incidence in children
by: G. M. Letifov, et al.
Published: (2019-11-01) -
Clinical characteristics and features of the monocytic link of innate immunity in children with extremely low body weight and severe bronchopulmonary dysplasia
by: L. S. Ustyantseva, et al.
Published: (2021-05-01) -
Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in the Russian Federation)
by: I. V. Feldblium, et al.
Published: (2022-11-01)